Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Eli Lilly said on Tuesday it had sued two mass compounders for selling unapproved products that contain tirzepatide, the main ...

Eli Lilly quickly disassociated itself from Hims & Hers after the telehealth company said it was selling the pharmaceutical ...

The Chief Executive of US pharmaceutical company Eli Lilly says it will be hard to come back from this moment.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

But at the same time, industry leaders are bracing for the news that they think is inevitable given Trump’s declaration in ...

President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result ...

Eli Lilly has launched weight-loss drug Mounjaro in India, priced at Rs 3,500 per injection for a 2.5mg dose. Will high costs ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... and diabetes fueled significant growth in the pharmaceutical sector. In the first quarter of 2025, healthcare ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...